BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 4549091)

  • 21. [The effect of spontaneous collaterals on acute experimental myocardial infarct].
    Schulz FW; Meesmann W; Schley G
    Med Welt; 1972 Sep; 23(40):1375-6. PubMed ID: 4655574
    [No Abstract]   [Full Text] [Related]  

  • 22. Verapamil in two reperfusion models of myocardial infarction. Temporary protection of severely ischemic myocardium without limitation of ultimate infarct size.
    Reimer KA; Jennings RB
    Lab Invest; 1984 Dec; 51(6):655-66. PubMed ID: 6503220
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of the proteinase inhibitor Trasylol on the mortality and infarct size in dogs with acute myocardial infarction.
    Eisenbach J; Heine H
    Pharmacol Res Commun; 1977 Jan; 9(1):79-92. PubMed ID: 301279
    [No Abstract]   [Full Text] [Related]  

  • 24. Influence of hypertonic mannitol on collateral coronary blood flow during acute coronary insufficiency.
    Watson JT; Willerson JT; Fixler DE; Sugg WL
    Surg Forum; 1973; 24():164-6. PubMed ID: 4805975
    [No Abstract]   [Full Text] [Related]  

  • 25. [Serotonin metabolism and several hemodynamic indices in experimental myocardial infarct].
    Gladkova AI; Vasil'ev IuM
    Patol Fiziol Eksp Ter; 1971; 15(1):17-20. PubMed ID: 5141920
    [No Abstract]   [Full Text] [Related]  

  • 26. [Use of phentolamine in acute period of myocardial infarct].
    Golikov AP; Maĭorov NI; Vaniev SB; Riabinin VA
    Sov Med; 1981; (11):10-4. PubMed ID: 7336230
    [No Abstract]   [Full Text] [Related]  

  • 27. The effect of Trasylol and vasopressin on experimental pancreatitis.
    Donaldson LA; Schenk WG
    Surg Gynecol Obstet; 1980 May; 150(5):657-60. PubMed ID: 6154320
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Myocardial blood flow following experimental coronary occlusion. Effects of diltiazem.
    Nakamura M; Kikuchi Y; Senda Y; Yamada A; Koiwaya Y
    Chest; 1980 Jul; 78(1 Suppl):205-9. PubMed ID: 7398408
    [No Abstract]   [Full Text] [Related]  

  • 29. Accelerated intravenous dosing of recombinant tissue-type plasminogen activator causes rapid but unstable reperfusion in a canine model of acute myocardial infarction.
    Gurbel PA; Anderson RD; MacCord CS; Scott H; Serebruany V; Herzog WR
    Coron Artery Dis; 1994 Nov; 5(11):929-36. PubMed ID: 7719525
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Metabolic and hemodynamic changes occurring in the course of myocardial infarct].
    Religa A
    Acta Physiol Pol; 1978; 29 Suppl 17():117-34. PubMed ID: 751456
    [No Abstract]   [Full Text] [Related]  

  • 31. [Experimental myocardial infarction (author's transl)].
    Tschirkov VF
    Basic Res Cardiol; 1974; 69(2):113-60. PubMed ID: 4546565
    [No Abstract]   [Full Text] [Related]  

  • 32. [Significance and efficacy of coronary artery reperfusion in acute experimental myocardial infarct].
    Kato H
    Nihon Kyobu Geka Gakkai Zasshi; 1974 Oct; 22(10):984-94. PubMed ID: 4474198
    [No Abstract]   [Full Text] [Related]  

  • 33. [Influence of vasodilation through dipyridamole on the extent of acute experimental infarct].
    Bleifeld W; Wende W; Meyer J; Bussmann WD
    Z Kardiol; 1974 Feb; 63(2):115-28. PubMed ID: 4409852
    [No Abstract]   [Full Text] [Related]  

  • 34. [Effect of collateral vessels of the heart on the mortality and electrocardiogram following acute experimental coronary occlusion].
    Schley G; Meesmann W; Schulz FW
    Lebensversicher Med; 1972 Nov; 24(6):141-9. PubMed ID: 4404530
    [No Abstract]   [Full Text] [Related]  

  • 35. Beneficial effects of N-acetyl cysteine on acute myocardial infarction in open-chest dogs.
    Such L; Morcillo E; Chorro FJ; Montoro A; Alberola A; Aparicio F; Viña J
    Arch Farmacol Toxicol; 1986 Apr; 12(1):37-40. PubMed ID: 3740968
    [No Abstract]   [Full Text] [Related]  

  • 36. [Behavior of tissue plasminogen activators and plasmin inhibitors in experimental myocardial infarct with and without trasylol].
    Wriedt-Lübbe I; Pfeiffer C; Blasini R; Blümel G
    Med Welt; 1978 Sep; 29(39):1526-8. PubMed ID: 308597
    [No Abstract]   [Full Text] [Related]  

  • 37. [Reperfusion and postconditioning in acute ST segment elevation myocardial infarction. A new paradigm for the treatment of acute myocardial infarction. From bench to bedside?].
    Lupi Herrera E; Gaspar J; González Pacheco H; Martínez Sánchez C; Pastelín Hernández G; Luna Ortiz P; Chávez Cosio E
    Arch Cardiol Mex; 2006; 76 Suppl 4():S76-101. PubMed ID: 17469337
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The cardioprotective action of preparations of biotechnological cytochrome c in acute myocardial ischemia].
    Gatsura VV; Sernov LN; Davidov ER
    Eksp Klin Farmakol; 1998; 61(2):27-9. PubMed ID: 9621169
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Venous use of nitroglycerin in acute myocardial infarct].
    Terzieva L
    Vutr Boles; 1984; 23(6):8-13. PubMed ID: 6442491
    [No Abstract]   [Full Text] [Related]  

  • 40. Infarct artery recanalization and collateral circulation in patients with myocardial infarction.
    Shen WF; Gong LS; Zhang JS; Cui LQ; Zhang X; Zheng AF
    Chin Med J (Engl); 1988 Dec; 101(12):915-8. PubMed ID: 3150741
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.